For the readers interested in the stock health of Osmotica Pharmaceuticals plc (OSMT). It is currently valued at $2.05. When the trading was stopped its value was $1.87.Recently in News on October 7, 2021, Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 Million. Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that it has entered into a note purchase agreement for up to $100 million of senior secured notes with funds managed by Athyrium Capital Management (“Athyrium”). You can read further details here
Osmotica Pharmaceuticals plc had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.9500 on 02/08/21, with the lowest value was $1.8300 for the same time period, recorded on 10/07/21.
Osmotica Pharmaceuticals plc (OSMT) full year performance was -67.20%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Osmotica Pharmaceuticals plc shares are logging -67.87% during the 52-week period from high price, and 12.02% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.83 and $6.38.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2295883 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Osmotica Pharmaceuticals plc (OSMT) recorded performance in the market was -50.24%, having the revenues showcasing -37.88% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 171.09M, as it employees total of 302 workers.
Market experts do have their say about Osmotica Pharmaceuticals plc (OSMT)
During the last month, 1 analysts gave the Osmotica Pharmaceuticals plc a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.1900, with a change in the price was noted -0.97. In a similar fashion, Osmotica Pharmaceuticals plc posted a movement of -32.12% for the period of last 100 days, recording 1,148,382 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for OSMT is recording 3.13 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Osmotica Pharmaceuticals plc (OSMT)
Raw Stochastic average of Osmotica Pharmaceuticals plc in the period of last 50 days is set at 8.63%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 15.07%. In the last 20 days, the company’s Stochastic %K was 7.76% and its Stochastic %D was recorded 10.01%.
Bearing in mind the latest performance of Osmotica Pharmaceuticals plc, several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -50.24%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -32.57%, alongside a downfall of -67.20% for the period of the last 12 months. The shares increased approximately by -33.01% in the 7-day charts and went up by -33.01% in the period of the last 30 days. Common stock shares were lifted by -37.88% during last recorded quarter.